What's the State of Healthtech Funding? It's an exciting time to be in Health & Life Sciences in Australia - with the data backing it. Our team's Aizaz Syed shared his thoughts on the state of healthtech, along with 100 other startup industry leaders and collaborators in Cut Through Venture’s 2024 State of Startup Funding Report Key Takeaways for the Australian Health landscape: 💰 $347m reported funding for Bio/Medtech (the 3rd most funded category) 💰 $129m reported funding for Healthtech 💰 Health/Bio is the 3rd category of most interest for both VCs & Angels 💰 Numerous new funds for health, including WEHI Ventures, Bupa Ventures & Brandon Capital fund VI 💰A few sizeable deals including our portfolio company Aravax ($66m Series B), Updoc ($20m Series B) & Kismet ($33m Seed) Whilst this is great progress, theres still a long way to go. Particularly on the Growth Capital, Commercialisatin and Talent front. However together, we can no doubt continue to create meaningful improvements and uplift the Australian Health & Life Science Ecosystem 💡 Want to know more about the State of Healthtech Funding in Australia? 👇🗞️ Have a read of the article by our own Emily Casey linked below
Article here: https://www.whatthehealth.io/p/the-state-of-aussie-healthtech-funding